Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1

Status

Withdrawn 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 10184Neoplasms 7810Carcinoma, Non-Small-Cell Lung 5760Prostatic Neoplasms 5024Colorectal Neoplasms 4606Lung Neoplasms 3725Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3083Multiple Myeloma 3082Pancreatic Neoplasms 2845Melanoma 2653Ovarian Neoplasms 2573Lymphoma 2571Carcinoma, Hepatocellular 2480Stomach Neoplasms 2330Recurrence 2230Head and Neck Neoplasms 2103Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1905Glioblastoma 1797Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Dizziness × Clear all
NCT04196933 2025-04-16

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Massachusetts Eye and Ear Infirmary

Phase NA Withdrawn
CNS

Dizziness, Migraine Disorders, Motion Sickness, Neuroma, Acoustic, Vestibular Diseases

NCT04859335 2024-08-02

EQUI-GAMMA

University Hospital, Toulouse

Phase NA Recruiting
50 enrolled
CNS

Dizziness, Neuroma, Acoustic

NCT04890132 2023-03-16

Vestibular Precision: Physiology & Pathophysiology

Massachusetts Eye and Ear Infirmary

Phase NA Unknown
90 enrolled
CNS

Dizziness, Labyrinth Diseases, Neuroma, Acoustic, Vestibular Diseases, Neurofibromatosis 2

NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Fujian Cancer Hospital

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡